Evaluation and Risk Factors of Post-traumatic Endophthalmitis

November 2, 2024 updated by: Hadeer Gamal AbdElmohsen Ahmed, Assiut University
  1. identify the incidence of post-traumatic endophthalmitis and the related risk factors influencing its development.
  2. study the clinical- microbiological profile and evaluate the functional and anatomical outcomes of post-traumatic endophthalmitis (PPTE).

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

41

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Evaluation and risk factors of post-traumatic endophthalmitis with general and optical examination on patients exposed to eye trauma and developed post-traumatic endophthalmitis

Description

Inclusion Criteria:

  • Patients exposed to eye trauma and developed post-traumatic endophthalmitis

Exclusion Criteria:

  • Patients who refuse to sign informed consent in this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Evaluation of post-traumatic endophthalmitis
  1. conception
  2. acquisition of data
  3. analysis of data
Diagnostic test: ophthalmic saline eye drops
for optical examination
Drug: Saline
Most one natural and not effects on study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge of clinical features outcomes of post-traumatic endophthalmitis
Time Frame: Baseline
Knowledge of clinical features which will be shown due to post-traumatic endophthalmitis
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The factors associated with a worse prognosis in post-traumatic endophthalmitis
Time Frame: Baseline
Discrimination the worst prognosis in post-traumatic endophthalmitis
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 10, 2024

Primary Completion (Estimated)

February 28, 2026

Study Completion (Estimated)

March 1, 2026

Study Registration Dates

First Submitted

October 31, 2024

First Submitted That Met QC Criteria

November 2, 2024

First Posted (Estimated)

November 5, 2024

Study Record Updates

Last Update Posted (Estimated)

November 5, 2024

Last Update Submitted That Met QC Criteria

November 2, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Ev. of post-traumatic Endoph.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endophthalmitis

Clinical Trials on ophthalmic saline eye drops

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe